# Giulia Orsi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giulia-orsi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,155 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 19 |
| i10-index | 29 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5020381243 |
| ORCID iD | 0000-0002-8458-4394 |
| Works | 120 |

## Researcher papers

- [Gastric cancer: Translating novels concepts into clinical practice](https://scholariq.org/papers/gastric-cancer-translating-novels-concepts-into-clinical-practice/)
- [Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients](https://scholariq.org/papers/management-of-adverse-events-with-tailored-sorafenib-dosing-prolongs-survival-of/)
- [Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer](https://scholariq.org/papers/soluble-trail-armed-human-msc-as-gene-therapy-for-pancreatic-cancer/)
- [EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting](https://scholariq.org/papers/eus-guided-gastroenterostomy-for-management-of-malignant-gastric-outlet/)
- [Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives](https://scholariq.org/papers/resistance-to-egfr-inhibitors-in-non-small-cell-lung-cancer-clinical-management/)
- [Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy](https://scholariq.org/papers/inducible-caspase9-mediated-suicide-gene-for-msc-based-cancer-gene-therapy/)
- [GD2 expression in breast cancer](https://scholariq.org/papers/gd2-expression-in-breast-cancer/)
- [MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma](https://scholariq.org/papers/msc-delivered-soluble-trail-and-paclitaxel-as-novel-combinatory-treatment-for/)
- [Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants](https://scholariq.org/papers/treatment-opportunities-and-future-perspectives-for-pancreatic-cancer-patients/)
- [Lenvatinib as a therapy for unresectable hepatocellular carcinoma](https://scholariq.org/papers/lenvatinib-as-a-therapy-for-unresectable-hepatocellular-carcinoma/)
- [Long-term outcomes of endoscopic ultrasound–guided gastroenterostomy: a prospective cohort study tracking symptom recurrence, reintervention timelines, and stent modifications over time](https://scholariq.org/papers/long-term-outcomes-of-endoscopic-ultrasound-guided-gastroenterostomy-a/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.